Clinical Pharmacology of Delafloxacin in Patients With Hepatic Impairment

Lignende værker

• Delafloxacin Pharmacokinetics in Subjects With Varying Degrees of Renal Function
  af: Hoover, Randall K., et al.
  Udgivet: (2017)
• Clinical Pharmacokinetics of Sulfobutylether‐β‐Cyclodextrin in Patients With Varying Degrees of Renal Impairment
  af: Hoover, Randall K., et al.
  Udgivet: (2018)
• Efficacy of Delafloxacin versus Moxifloxacin against Bacterial Respiratory Pathogens in Adults with Community-Acquired Bacterial Pneumonia (CABP): Microbiology Results from the Delafloxacin Phase 3 CABP Trial
  af: McCurdy, Sandra, et al.
  Udgivet: (2020)
• Human Target Attainment Probabilities for Delafloxacin against Escherichia coli and Pseudomonas aeruginosa
  af: Hoover, Randall, et al.
  Udgivet: (2017)
• 2378. Resolution of Signs and Symptoms (S&S) of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) With Delafloxacin (DLX) IV/Oral Therapy
  af: Pullman, John, et al.
  Udgivet: (2018)